论文信息 - Preclinical Development The CXCR 2 Antagonist , SCH-527123 , Shows Antitumor Activity andSensitizesCells toOxaliplatin inPreclinical Colon Cancer Models - 字舞流文

Preclinical Development The CXCR 2 Antagonist , SCH-527123 , Shows Antitumor Activity andSensitizesCells toOxaliplatin inPreclinical Colon Cancer Models

H. Lenz | A. Gerger | M. LaBonte | R. Ladner | Dongyun Yang | Wu Zhang | N. Petasis | P. Bohanes | L. Benhaim | D. Páez | S. Louie | Y. Ning | D. O. Rosenberg | K. Venkata